SilverSky Announces AI Initiative with MIT SuperCloud
SilverSky, with its over 20 years of experience and extraordinary data sets, and MIT Connection Science's Dr.
This is an excellent example of how the academic community can partner with the business community to support efforts to stay ahead of those trying to harm the cybersecurity space. "This has always been an area that I wanted SilverSky to be a part of by partnering with some of the best mathematical minds in the world to help better protect our customers," said
MIT Connection Science is led by Prof. Alex "Sandy" Pentland, which uses network science to access and change real-world human behavior. Prof. Pentland is the Toshiba Professor of Media, Arts, and Sciences at MIT. Sandy also holds a triple appointment at MIT in Media Arts and Sciences, Engineering Systems Division and with the Sloan School of Business. Dr.
About SilverSky
Medium-sized enterprises face the same cybersecurity threats, compliance mandates, and business risk as Fortune 500 companies. SilverSky is a leader in enabling these companies to meet regulatory requirements, proactively respond to threats, and rapidly reduce risk. State-of-the-art MDR services are delivered through their SOCs, which were developed based on military-grade security, and are powered by the latest integrated technology. SilverSky has more than 20 years of operational success defending thousands of customers in some of the most demanding industry sectors. Visit www.silversky.com.
Company Contact:
Vice President, Marketing
SilverSky
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/silversky-announces-ai-initiative-with-mit-supercloud-302138146.html
SOURCE SilverSky
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Invitation to media and analyst briefing for Ericsson Q2 2026 report
- SKF and Leaderdrive form a venture for precision components in humanoids
- Celea Therapeutics Announces $180 Million Financing to Advance Deupirfenidone as a Potential New Standard of Care to Treat Idiopathic Pulmonary Fibrosis (IPF)
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share